Bacteriuria Eradication Through Probiotics
(BERP Trial)
Trial Summary
What is the purpose of this trial?
Many children who catheterize their bladders because of spina bifida or other neurologic disorders have bacteriuria. This can lead to urinary tract infections by bacteria from the gut which colonize the vagina and are carried into the bladder during catheter passage. We seek to test whether oral administration of probiotic bacteria can "displace" these vagina-derived uropathogens and reduce or prevent bacteriuria in girls with spina bifida who empty their bladders through catheterization.
Research Team
Eric A Jones, M.D.
Principal Investigator
Texas Children's Hospital, Baylor College of Medicine
Eligibility Criteria
Inclusion Criteria
Treatment Details
Interventions
- Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 (Probiotic)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor College of Medicine
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborator
London Health Sciences Centre OR Lawson Research Institute of St. Joseph's
Collaborator
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Collaborator
Chr Hansen
Industry Sponsor
Lawson Health Research Institute
Collaborator